Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
825,20 €
0,66 %
Sell Eli Lilly Corp.
Sell Eli Lilly Corp.
Buy Eli Lilly Corp.
Buy Eli Lilly Corp.
Buy Eli Lilly Corp.
Buy Eli Lilly Corp.
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Citigroup Inc. from $370.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $375.00 price target on the stock, up previously from $360.00.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at UBS Group AG from $447.00 to $498.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Bank of America Co. from $450.00 to $500.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Wells Fargo & Company from $500.00 to $615.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Morgan Stanley from $560.00 to $617.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $630.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $630.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Morgan Stanley from $617.00 to $640.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Argus from $470.00 to $620.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $630.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Wells Fargo & Company from $615.00 to $650.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
BullishBabe in Nike Inc. B diskutieren